4 Recruiting Recurrent Lung Non-Small Cell Carcinoma Clinical Trials in Alabama
Explore active recurrent lung non-small cell carcinoma research studies enrolling across Alabama. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Recurrent Lung Non-Small Cell Carcinoma Studies in Alabama
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
View Study & Checklist ➔